Infusion of a lipid emulsion in healthy men decreases the serotonergic response

Neuroendocrinology
Brigitte M SondermeijerMireille J Serlie

Abstract

Subjects with obesity and insulin resistance display a low response to a serotonergic challenge test. One of the hallmarks of obesity and insulin resistance is elevated plasma free fatty acids (FFAs). We hypothesize that increasing plasma FFA by infusion of a lipid emulsion, may be a contributing component leading to decreased serotonergic responsivity in healthy young men. Ten lean healthy men, 23.6 ± 5.0 years and BMI 22.6 ± 1.9 kg/m(2), were included. Serotonergic responsivity was assessed using the prolactin response to infusion with citalopram, a selective serotonin reuptake inhibitor, which is a validated tool to assess serotonergic tone. All participants received a lipid/heparin emulsion (Intralipid) infusion during 6 h. Saline infusion was used as a control. To evaluate a possible effect of heparin per se on prolactin, four out of the ten subjects also received heparin only during 6 h without the serotonergic challenge test. Plasma prolactin increased by 74.3 ± 15.5% during saline infusion. Intralipid infusion increased plasma FFA from 0.5 ± 0.05 to 2.3 ± 0.2 mmol/l (p < 0.001). The increase in plasma prolactin during Intralipid infusion was significantly lower (39.3 ± 10%; p < 0.001 compared to saline infusion). Hepari...Continue Reading

References

Jun 1, 1994·The Journal of Clinical Investigation·G BodenL Rossetti
Apr 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E SeifritzE Holsboer-Trachsler
Jan 23, 1999·The Journal of Clinical Investigation·A DresnerG I Shulman
Sep 4, 1999·The Netherlands Journal of Medicine·R Le MoliW M Wiersinga
Apr 15, 2000·Nature·M W SchwartzD G Baskin
Jul 4, 2001·Psychopharmacology·M J AttenburrowP J Cowen
Jul 27, 2002·Science·Lora K HeislerJoel K Elmquist
Dec 12, 2002·Diabetes·Suad EfendicSergei V Zaitsev
Mar 26, 2003·Journal of Psychiatric Research·Olaf MoellerAndreas Erfurth
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Matthew F MuldoonStephen B Manuck
Mar 5, 2004·Psychopharmacology·Janine D FloryMatthew F Muldoon
Jun 19, 2004·Psychopharmacology·J David Sweatt
Sep 14, 2004·The International Journal of Neuropsychopharmacology·George I PapakostasMaurizio Fava
Feb 8, 2005·Psychopharmacology·Andrew C Harris, Jonathan C Gewirtz
Mar 1, 2005·Nature Medicine·Tony K T LamLuciano Rossetti
Nov 24, 2005·The Journal of Clinical Endocrinology and Metabolism·Matthew F MuldoonStephen B Manuck
Mar 28, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Emily R HawkenNicholas J Delva
Jul 19, 2006·Neuron·Lora K HeislerMichael A Cowley
Oct 3, 2006·Journal of Affective Disorders·Arif KhanWalter A Brown
Jan 24, 2007·Biological Psychiatry·Stefan KloiberSusanne Lucae
May 4, 2007·Diabetes & Metabolism·S MigrenneC Cruciani-Guglielmacci
Dec 15, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Christopher J PriceAlastair V Ferguson
Nov 27, 2008·JAMA : the Journal of the American Medical Association·Mary A WhooleyWarren S Browner
Jun 23, 2010·Diabetes·Anna KarmiPirjo Nuutila

❮ Previous
Next ❯

Citations

Nov 7, 2015·Reviews in Endocrine & Metabolic Disorders·Giulia RastrelliMario Maggi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.